Title:
【発明の名称】ステロイド化合物投与のための改良された製剤
Document Type and Number:
Japanese Patent JP2002507960
Kind Code:
A
Abstract:
Improved cyclodextrin formulations for the administration of 5 beta steroids including alpha etiocholanolone, beta etiocholonolone, and etiocholandione are provided. Also provided are cyclodextrin formulations including at least one of the 5 beta steroids and DHEA. The formulations are suitable for parenteral administration, particularly intravenous administration and are also suitable for treating a condition which responds to treatment with the 5 beta steroids alone or together with DHEA, particularly where it is desired to decrease the amount of DHEA administered, including such conditions as obesity, diabetes syndrome, diabetes-associated hypercorticoidism or combinations thereof, anemic disorders including but not limited to aplastic anemia and anemia associated with renal failure or chemotherapy-induced or radiation-induced anemia or neutropenia, and autoimmune or inflammatory disorders such as lupus erythematosus.
More Like This:
| WO/2011/124876 | A FREEZE-DRIED TABLET |
| WO/2017/077445 | DOSAGE REGIMEN FOR A PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR |
| JPH0283314 | STABLE AQUEOUS SOLUTION OF FAT-SOLUBLE SUBSTANCE |
Inventors:
Rubinfeld Joseph
Vida Julius A.
Bradlow H. Leon
Feynman Elliott El.
Vida Julius A.
Bradlow H. Leon
Feynman Elliott El.
Application Number:
JP51903597A
Publication Date:
March 12, 2002
Filing Date:
November 12, 1996
Export Citation:
Assignee:
Super Gen Ink.
International Classes:
A61K9/00; A61K31/56; A61K31/565; A61K47/40; A61K47/48; A61P3/04; A61P3/10; A61P7/06; A61P43/00; (IPC1-7): A61K47/40; A61K31/56; A61K47/48; A61P3/04; A61P3/10; A61P7/06; A61P43/00
Attorney, Agent or Firm:
Shimizu Hatsushi (1 person outside)